Dressler's syndrome
|
Pericarditis Microchapters |
|
|---|
|
Diagnosis |
|
Treatment |
|
Surgery |
|
Case Studies |
|
Dressler's syndrome On the Web |
|
American Roentgen Ray Society Images of Dressler's syndrome |
|
Blogs on Dressler's syndrome</small> |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mohammed A. Sbeih, M.D.[2] Phone:617-849-2629; Cafer Zorkun, M.D., Ph.D. [3]
Synonyms and keywords: Postmyocardial infarction syndrome; post MI pericarditis; PMIS; post-cardiac injury syndrome
Overview
Dressler's syndrome or post myocardial infarction syndrome is a form of pericarditis that occurs in the setting of injury to the heart as a result of myocardial infarction[1]. Dressler's syndrome typically occurs 2 to 10 weeks after myocardial infarctionit's[2]. This differentiates Dressler's syndrome from the much more common post myocardial infarction pericarditis which occurs between days 2 and 4 after myocardial infarction.
Historical Perspective
It was first characterized by William Dressler in 1956.[3][4][5][6] It should not be confused with the Dressler's syndrome of hemoglobinuria named for Lucas Dressler, who characterized it in 1854.[7][8]
Pathophysiology
Dressler's syndrome is believed to result from an autoimmune inflammatory reaction to myocardial neo-antigens. It usually occurs within weeks or months of the Infarction due to antiheart antibodies, this begins with myocardial injury that releases cardiac antigens and stimulates antibody formation. The immune complexes that are generated then deposit onto the pericardium and causes the inflamation. The autoimmune response and syndrome may also appear after pulmonary embolism.[9]
Gross Pathology Images
Fibrinous pericarditis: Gross, external view of localized pericarditis over an acute infarction.
Causes
Differentiating Dressler's syndrome from other Conditions
Dressler's syndrome typically occurs 2 to 10 weeks after a myocardial infarction has occurred[10]. This differentiates Dressler's syndrome from the much more common post myocardial infarction pericarditis that occurs in 17 to 25% of cases of acute myocardial infarction between days 2 and 4 after the myocardial infarction. Dressler's syndrome also needs to be differentiated from pulmonary embolism, another identifiable cause of pleuritic (and non-pleuritic) chest pain in people who have been hospitalized and/or undergone surgical procedures within the preceding weeks.
Epidemiology and Demographics
In the setting of myocardial infarction, Dressler's syndrome occurs in about 7% of cases[11]. Dressler's syndrome was more commonly seen in the era prior to reperfusion, but its incidence has markedly decreased in the reperfusion era, presumably because of smaller infarct sizes [12].
Natural History, Complications, Prognosis
- Pericardial effusion may result from the accumulation of fluids as a result of inflammation in the pericardial sac.
- Cardiac tamponade can occur if the accumulation of fluids in the pericardium is large enough and rapid enough.
- Constrictive pericarditis can occur if there is a chronic inflammatory response
Diagnosis
Symptoms
The syndrome consists of a persistent low-grade fever, and chest pain which is usually pleuritic in nature. The symptoms tend to occur after a few weeks or even months after myocardial infarction and tend to subside in a few days.
Physical Examination
Cardiovascular Examination
A pericardial friction rub, and /or a pericardial effusion is present.
Laboratory Findings
Elevated ESR.
Treatment
Dressler's syndrome is typically treated with high dose (up to 650 mg PO q 4 to 6 hours) enteric-coated aspirin. Acetominophen can be added for pain management as this does not affect the coagulation system. Anticoagulants should be discontinued if the patient develops a pericardial effusion.
NSAIDs such as ibuprofen should be avoided in the peri-infarct period as they:
- Increase the risk of reinfarction
- Adversely impact left ventricular remodeling
- Block the effectiveness of aspirin
2013 Revised ACCF/AHA Guidelines for the Management of ST-Elevation Myocardial Infarction (DO NOT EDIT)[13]
Management of Pericarditis After STEMI (DO NOT EDIT)[13]
| Class I |
| "1. Aspirin is recommended for treatment of pericarditis after STEMI.[14](Level of Evidence: B)" |
| Class III (Harm) |
| "1. Glucocorticoids and nonsteroidal antiinflammatory drugs are potentially harmful for treatment of pericarditis after STEMI. [15][16](Level of Evidence: B)" |
| Class IIb |
| "1. Administration of acetaminophen, colchicine, or narcotic analgesics may be reasonable if aspirin, even in higher doses, is not effective. (Level of Evidence: B)" |
Sources
- The 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction [17]
- The 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction [18]
References
- ↑ Hutchcroft BJ (July 1972). "Dressler's syndrome". Br Med J 3 (5817): 49. PMID 5039567.
- ↑ Krainin F, Flessas A, Spodick D (1984). "Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram.". N Engl J Med 311 (19): 1211-4. PMID 6493274.
- ↑ DRESSLER W (1956). "A post-myocardial infarction syndrome; preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis.". J Am Med Assoc 160 (16): 1379-83. PMID 13306560.
- ↑ Bendjelid K, Pugin J (November 2004). "Is Dressler syndrome dead?". Chest 126 (5): 1680–2. doi:10.1378/chest.126.5.1680. PMID 15539743.
- ↑ Streifler J, Pitlik S, Dux S, et al (April 1984). "Dressler's syndrome after right ventricular infarction". Postgrad Med J 60 (702): 298–300. PMID 6728756.
- ↑ Dressler W (January 1959). "The post-myocardial-infarction syndrome: a report on forty-four cases". AMA Arch Intern Med 103 (1): 28–42. PMID 13605300.
- ↑ synd/3982 at Who Named It
- ↑ L. A. Dressler. Ein Fall von intermittirender Albuminurie und Chromaturie. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin, 1854, 6: 264-266.
- ↑ Jerjes-Sánchez C, Ramírez-Rivera A, Ibarra-Pérez C (1996). "The Dressler syndrome after pulmonary embolism.". Am J Cardiol 78 (3): 343-5. PMID 8759817.
- ↑ Krainin F, Flessas A, Spodick D (1984). "Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram.". N Engl J Med 311 (19): 1211-4. PMID 6493274.
- ↑ Krainin F, Flessas A, Spodick D (1984). "Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram.". N Engl J Med 311 (19): 1211-4. PMID 6493274.
- ↑ Tofler GH, Muller JE, Stone PH, Willich SN, Davis VG, Poole WK et al. (1989). "Pericarditis in acute myocardial infarction: characterization and clinical significance.". Am Heart J 117 (1): 86-92. PMID 2643287.
- ↑ 13.0 13.1 O'Gara PT, Kushner FG, Ascheim DD, et al. (December 2012). "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0b013e3182742c84. PMID 23247303.
- ↑ Berman J, Haffajee CI, Alpert JS (June 1981). "Therapy of symptomatic pericarditis after myocardial infarction: retrospective and prospective studies of aspirin, indomethacin, prednisone, and spontaneous resolution". Am. Heart J. 101 (6): 750–3. PMID 7234652.
- ↑ Bulkley BH, Roberts WC (February 1974). "Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm". Am. J. Med. 56 (2): 244–50. PMID 4812079.
- ↑ Silverman HS, Pfeifer MP (February 1987). "Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction". Am. J. Cardiol. 59 (4): 363–4. PMID 3812291.
- ↑ Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK (August 2004). "ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)". Circulation 110 (9): e82–292. PMID 15339869.
- ↑ Antman EM, Hand M, Armstrong PW, et al (January 2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078.
See also
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
